NattoPharma to conduct highest-dosage K2 study in cardio clinical trial

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Vitamin K2 is overlooked in cardiovascular health, according to a review paper published amid calls to roll out a recommended daily intake. Published in Open... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Glanbia plc announced it will sell its 40% holding in Glanbia Ireland to Glanbia Co-op for €307 million (US$351 million). Amazon set... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The vitamin K2 market has welcomed a new product called Menatto. Touted as “The Japanese Original,” the vitamin is produced by J-Oil Mills, a nutra food... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Kappa Bioscience, a vitamin production company, is enhancing its stability testing with its new subsidiary Kappa Solutions – a rebrand from its Synthetica.

FormattedPicture

NUTRITION & HEALTH NEWS

Mankai, a patented strain of Wolffia globosa, has the potential to “change the way people consume vegetables and leverage food for health.”

trans